<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01225484</url>
  </required_header>
  <id_info>
    <org_study_id>21-315 ex 09/10</org_study_id>
    <nct_id>NCT01225484</nct_id>
  </id_info>
  <brief_title>Perioperative Analgesia After Knee Arthroplasty</brief_title>
  <official_title>Perioperative Analgetic Therapy After Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Landeskrankenhaus Feldbach</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Landeskrankenhaus Feldbach</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two accepted methods of pain control in knee
      arthroplasty surgery.The first method combines the periarticular injection of ropivacaine
      with continuous blockade of the femoral nerve.The second method uses periarticular
      infiltration of ropivacaine in combination with an bolus of ropivacaine into an
      intraarticular catheter placed intraoperatively followed by a continuous intraarticular
      infusion of ropivacaine. All patient will also receive a sustained-release oral opioid and
      oral rescue opioids determined by pain severity using the Visual Analog Scale (VAS)
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Static and dynamic pain scores (VAS)</measure>
    <time_frame>72 h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum knee flexion (active/passive)&gt;= 90Â°</measure>
    <time_frame>72 h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">123</enrollment>
  <condition>Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>CFNB, periarticular infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Intraarticular catheter, periarticular infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous femoral nerve block + periarticular infiltration</intervention_name>
    <description>Initial bolus of ropivacaine 5mg/ml 30mls into the femoral-nerve-catheter preoperatively. Periarticular infiltration of ropivacaine 2mg/ml 150 mls intraoperatively. Continuous perineural infusion of ropivacaine 2mg/ml at a rate of 6 mls/hr postoperatively. Rate can be adjusted to achieve optimal pain control and avoid motor blockade.</description>
    <arm_group_label>CFNB, periarticular infiltration</arm_group_label>
    <arm_group_label>Intraarticular catheter, periarticular infiltration</arm_group_label>
    <other_name>CFNB plus periarticular infiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraarticular and periarticular ropivacaine</intervention_name>
    <description>Periarticular infiltration of 150 mls ropivacaine 2mg/ml intraoperatively, intraarticular injection of 40 mls ropivacaine 2 mg/ml at skin closure followed by infusion of ropivacaine 2 mg/ml at a rate of 4 mls/hr delivered by an intraarticular catheter until the morning of postoperative day 3.</description>
    <arm_group_label>Intraarticular catheter, periarticular infiltration</arm_group_label>
    <other_name>Intraarticular ropivacaine plus periarticular ropivavaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective primary knee arthroplasty

          -  ASA I,II,&amp;III patients

          -  Spinal Anaesthesia

        Exclusion Criteria:

          -  Patients refusing consent

          -  Contraindications to regional anaesthesia

          -  Preexisting neurological disease

          -  Alcohol or drug abuse

          -  Inability to use the outcome assessment tools

          -  Wheel chair or walker dependent

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl Trauner, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>LKH Feldbach</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karl Trauner, M.D.</last_name>
    <phone>+43 3152 899 3701</phone>
    <email>karl.trauner@lkh-feldbach.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angelika Rohrleitner, M.D.</last_name>
    <phone>+43 3152 899 3701</phone>
    <email>angelika.rohrleitner@lkh-feldbach.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>LKH Feldbach</name>
      <address>
        <city>Feldbach</city>
        <zip>A-8330</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2010</study_first_submitted>
  <study_first_submitted_qc>October 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2010</study_first_posted>
  <last_update_submitted>April 8, 2015</last_update_submitted>
  <last_update_submitted_qc>April 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Landeskrankenhaus Feldbach</investigator_affiliation>
    <investigator_full_name>Karl Trauner</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Knee arthroplasty, perioperative analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

